Enveda Series E: $311M
Enveda raised $311 million in a series e round led by Catalio Capital Management, announced Sept. 22.
Facts
- $311 million
- USD
- Series E
- Sep 22, 2026
- Equity
- $2 billion (officially disclosed)
Investors
Use of funds
bring more nature-derived AI drugs into clinical trials
Sources
- 1.Enveda secures $311M to bring more nature-derived AI drugs into clinical trials — TechCrunch Startups, Sep 23, 2026